Highlights• Members of the public in Australia considered reimbursement and justifiable recompensation of costs related to organ donation to be legitimate ways of supporting living donors.• Financial payment beyond reimbursement was regarded as morally reprehensible.

Many patients waiting for a kidney transplant will die before a suitable organ becomes available.

Newswise — Washington, DC (April 23, 2015) — To address the growing transplant organ shortage, members of the public seem to support eliminating disincentives, but are against providing financial incentives, to living kidney donors. The findings come from a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

As transplant waiting lists around the world continue to grow longer over time, there is increasing debate about whether it’s ethical to provide incentives for living donations. Some say this could lead to exploitation of financially vulnerable individuals, and it might discourage altruistic donations that form the basis of current policies.

Allison Tong, PhD, MPH (The University of Sydney) and her colleagues conducted a study to gain in-depth insights into public opinion on this controversy. To do so, they established 12 focus groups with 113 participants who were recruited from the general public in 3 Australian states.

Participants considered reimbursement and justifiable recompensation of costs related to donation to be legitimate ways of supporting donors. Financial payment beyond reimbursement was regarded as morally reprehensible and would threaten community values of goodwill, human dignity, and fairness, with the potential for exploitative commercialism. Some participants believed that regulated compensation could be a defensible strategy to increase donation rates provided that mechanisms are in place to protect donors.

“Our findings suggest that there could be strong public resistance to policies that would support financial inducement for living kidney donors. Instead, addressing the removal of disincentives would be more acceptable to the general public,” said Dr. Tong. Given that living kidney donation programs depend on members of the public to come forward to donate, the public should be actively engaged in ongoing debates, she added.

Study co-authors include Angelique Ralph, BPsych, JeremyChapman, MBBS, FRACP, Germaine Wong, MBBS, PhD, John Gill, MD, Michelle Josephson, MD, and Jonathan Craig, MBBS, PhD.

Disclosures: The authors reported no financial disclosures.

The article, entitled “Focus Group Study of Public Opinion about Paying Living Kidney Donors in Australia,” will appear online at http://cjasn.asnjournals.org/ on April 23, 2015.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 15,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

Register for reporter access to contact details

Clinical Journal of the American Society of Nephrology